Zevia PBC's price targets lowered by Goldman Sachs to $1.25 and Morgan Stanley to $2.00.
Zevia PBC (NYSE:ZVIA) had its price target lowered by Goldman Sachs from $3.00 to $1.25, while Morgan Stanley dropped their price target from $3.00 to $2.00. The company reported ($0.10) EPS for the quarter, meeting analysts' consensus estimates. Shares of Zevia PBC have a 1-year low of $0.78 and a 1-year high of $4.80, with a market cap of $64.05 million and a beta of 0.66.
May 11, 2024
3 Articles